Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Biogen
Company Monitoring Page for Biogen
latest headlines for company on cafepharma
Biogen backs away from AGTC after gene therapy failure
BioPharma Dive
Thu, 12/13/18 - 09:10 pm
Tags:
gene therapy
,
Biogen
,
Applied Genetic Technologies
Biogen bails on AGTC after ocular gene therapy flunks trial
Fierce Biotech
Thu, 12/13/18 - 12:20 pm
Tags:
Applied Genetic Technologies
,
gene therapy
,
Biogen
,
rAAV2tYF-CB-hRS1
Biogen opts in for Ionis' ALS candidate, plans pivotal trial
BioCentury
Thu, 12/6/18 - 06:56 pm
Tags:
BIIB067
,
Biogen
,
Ionis Pharmaceuticals
,
ALS
Biogen tasks HitGen with discovering neurological leads
Fierce Biotech
Wed, 11/21/18 - 09:51 am
Tags:
Biogen
,
HitGen
,
drug discovery
,
DNA
Biogen Ups Investment in Biosimilar Drug Maker Samsung Bioepis by $700 Million
BioSpace
Wed, 11/7/18 - 12:29 pm
Tags:
Biogen
,
Samsung Bioepis
,
biosimilars
This Big Pharma Bet Isn't Paying Off Yet
Motley Fool
Sun, 10/28/18 - 07:42 pm
Tags:
Big Pharma
,
biosimilars
,
Novartis
,
Amgen
,
Merck
,
Pfizer
,
Biogen
Biogen’s ‘positive’ Alzheimer’s trial has a problem with small numbers
Stat
Thu, 10/25/18 - 11:31 am
Tags:
Biogen
,
Eisai
,
BAN2401
,
Alzheimer's disease
Forward Pharma loses appeal in Tecfidera patent dispute with Biogen
Reuters
Wed, 10/24/18 - 11:46 pm
Tags:
Biogen
,
Tecfidera
,
MS
,
Forward Pharma
Biogen Rides the Spinraza Wave to Double-Digit Growth
Motley Fool
Wed, 10/24/18 - 11:35 pm
Tags:
Biogen
,
earnings
Biogen sees two phase 2 failures: In sciatica and in its lupus collaboration with UCB
Fierce Biogen
Tue, 10/23/18 - 01:40 pm
Tags:
UCB Pharma
,
Biogen
,
dapirolizumab pegol
,
vixotrigine
,
lupus
,
sciatica
UCB, Biogen admit defeat in PhII lupus trial, adding to a string of late-stage failures in the field
Endpoints
Tue, 10/23/18 - 10:37 am
Tags:
UCB Pharma
,
Biogen
,
dapirolizumab pegol
,
DZP
,
lupus
,
clinical trials
Up on Deck! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/20/18 - 11:16 pm
Tags:
earnings
,
biotech
,
Biogen
,
Alexion Pharmaceuticals
,
Bristol-Myers Squibb
,
Celgene
,
Gilead Sciences
,
Merck
,
Biomarin
,
Galapagos
,
Seattle Genetics
,
Dr Reddy's
Researchers behind Biogen’s breakthrough drug win big at ‘Oscars of science’
Stat
Thu, 10/18/18 - 12:14 am
Tags:
Biogen
,
Spinraza
Biogen's new Spinraza data for earlier use 'pretty amazing,' analyst says
Fierce Pharma
Mon, 10/8/18 - 11:37 pm
Tags:
Biogen
,
Spinraza
,
spinal muscular atrophy
,
SMA
Moody's picks 5 early winners in biosimilar market
Biopharma Dive
Fri, 10/5/18 - 09:01 pm
Tags:
biosimilars
,
Pfizer
,
Biogen
,
Novartis
,
Amgen
,
Mylan Labs
Parkinson's Patient Files Discrimination Lawsuit Against Biogen, Adding to Other Former Employee Suits
BioSpace
Fri, 10/5/18 - 12:05 pm
Tags:
Biogen
,
discrimination
,
disabilities
,
Parkinson's Disease
AbbVie's not the only one facing kickbacks scrutiny. Add Biogen, Sanofi, Gilead and more
Fierce Pharma
Tue, 09/25/18 - 07:19 pm
Tags:
AbbVie
,
Biogen
,
Sanofi
,
Gilead Sciences
Biogen, Teva benefit as payers ease up on multiple sclerosis meddling: analyst
Fierce Pharma
Fri, 08/31/18 - 11:44 pm
Tags:
Biogen
,
Teva Pharmaceutical
,
MS
,
multiple sclerosis
,
payers
Biogen and Eisai Report Phase Ib Extension Data for Alzheimer’s Trial
BioSpace
Tue, 08/28/18 - 07:54 pm
Tags:
Biogen
,
Eisai
,
aducanumab
,
clinical trials
,
Alzheimer's disease
Biogen's Spinraza gets an early no-go from NICE
Biopharma Dive
Wed, 08/15/18 - 09:57 am
Tags:
Biogen
,
UK
,
NICE
,
Spinraza
,
SMA
,
spinal muscular atrophy
Pages
« first
‹ previous
…
29
30
31
32
33
34
35
36
37
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.